Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-12-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2012.04.021PMID 22521844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple-Locus Variable Number Tandem Repeat Analysis for Streptococcus pneumoniae: Comparison with PFGE and MLST

  2011cited by this paper
• Population Structure of Invasive Streptococcus pneumoniae in the Netherlands in the Pre-Vaccination Era Assessed by MLVA and Capsular Sequence Typing

  2011cited by this paper
• Sequence Diversity within the Capsular Genes of Streptococcus pneumoniae Serogroup 6 and 19

  2011cited by this paper
• Temporal Trends in Invasive Pneumococcal Disease and Pneumococcal Serotypes over 7 Decades

  2010cited by this paper
• Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands

  2010cited by this paper
• Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.

  2010cited by this paper
• Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development.

  2010cited by this paper
• Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.

  2009cited by this paper
• Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007

  2009cited by this paper
• Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence

  2009cited by this paper
• Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.

  2008cited by this paper
• Molecular assessment of invasive Streptococcus pneumoniae serotype 1 in Brazil: evidence of clonal replacement.

  2008cited by this paper
• Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

  2008cited by this paper
• Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

  2008cited by this paper
• Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.

  2008cited by this paper
• The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease

  2008cited by this paper
• Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

  2007cited by this paper
• Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States

  2007cited by this paper
• Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

  2007cited by this paper
• Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae

  2007cited by this paper
• Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine.

  2007cited by this paper
• Pre- and Postvaccination Clonal Compositions of Invasive Pneumococcal Serotypes for Isolates Collected in the United States in 1999, 2001, and 2002

  2006cited by this paper
• Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.

  2006cited by this paper
• Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

  2005cited by this paper
• Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

  2005cited by this paper
• Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

  2003cited by this paper
• Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

  2003cited by this paper
• Nomenclature of Major Antimicrobial-Resistant Clones of Streptococcus pneumoniae Defined by the Pneumococcal Molecular Epidemiology Network

  2001cited by this paper
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children

  2000cited by this paper
• The Three Major Spanish Clones of Penicillin-Resistant Streptococcus pneumoniae Are the Most Common Clones Recovered in Recent Cases of Meningitis in Spain

  1999cited by this paper
• A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

  1998cited by this paper
• Six newly recognized types of Streptococcus pneumoniae

  1995cited by this paper
• Pneumococcal disease: prospects for a new generation of vaccines.

  1994cited by this paper
• Horizontal transfer of multiple penicillin‐binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae

  1991cited by this paper
• Antibody response to pneumococcal vaccination in children younger than five years of age.

  1983cited by this paper
• Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines.

  1981cited by this paper
• Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.

  1981cited by this paper
• Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage.

  1981cited by this paper
• The quellung reaction, a neglected microbiologic technique.

  1976cited by this paper
• Laboratory diagnosis of Pneumococcus infections.

  1960cited by this paper
• CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS

  1929cited by this paper
• In the United States

  1921cited by this paper

• Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review

  2024cites this paper
• Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome

  2021cites this paper
• Impact of 7-valent versus 10-valent pneumococcal conjugate vaccines on primary care consultations across various age groups in the Netherlands, 5 years after the switch: A time-series analysis.

  2021cites this paper
• Immune surveillance for vaccine-preventable diseases

  2020cites this paper
• Vaccines for the elderly: current use and future challenges

  2018cites this paper
• Childhood fever in out-of-hours general practice

  2018cites this paper
• Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine

  2018cites this paper
• Reductions in otitis and other respiratory tract infections following childhood pneumococcal vaccination

  2018cites this paper
• Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands

  2018cites this paper
• Three Cases of Invasive Pneumococcal Disease with Multiple Serotype Replacement in Vaccinated Children

  2017cites this paper
• Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.

  2017cites this paper
• Sequencing of the variable region of rpsB to discriminate between Streptococcus pneumoniae and other streptococcal species

  2017cites this paper
• Application of capsular sequence typing (CST) to serotype non-viable Streptococcus pneumoniae isolates from an old collection

  2016cites this paper
• Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes.

  2016cites this paper
• Pneumococcal colonization in older adults

  2016cites this paper
• Theory and strategy for Pneumococcal vaccines in the elderly

  2015cites this paper
• Multi-Serotype Pneumococcal Nasopharyngeal Carriage Prevalence in Vaccine Naïve Nepalese Children, Assessed Using Molecular Serotyping

  2015cites this paper
• Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples

  2015cites this paper
• A review of guidance on immunization in persons with defective or deficient splenic function

  2015cites this paper
• Genotyping Streptococcus pneumoniae.

  2015cites this paper
• Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine

  2015cites this paper
• Streptococcus pneumoniae Enhances Human Respiratory Syncytial Virus Infection In Vitro and In Vivo

  2015cites this paper
• Using Standardized Interpretation of Chest Radiographs to Identify Adults with Bacterial Pneumonia—Guatemala, 2007–2012

  2015cites this paper
• Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany

  2015cites this paper
• Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

  2015cites this paper
• Use of Surveillance Data to Assess the Impact of Vaccination on Circulating Rotavirus Strains.

  2015cites this paper
• vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine

  2015cites this paper
• The post-vaccine microevolution of invasive Streptococcus pneumoniae

  2015cites this paper
• Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea.

  2014cites this paper
• The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition

  2014cites this paper
• Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data.

  2014cites this paper
• Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia.

  2014cites this paper
• Acute flaccid paralysis following enterovirus D68 associated pneumonia, France, 2014.

  2014cites this paper
• Pneumokokkenziekte

  2014cites this paper
• Interactions between Paramyxoviruses and Bacteria: Implications for Pathogenesis and Intervention

  2014cites this paper
• Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study

  2013cites this paper
• Measurement of Pneumococcal Polysaccharide Vaccine Responses for Immunodeficiency Diagnostics: Combined IgG Responses Compared to Serotype Specific IgG Responses

  2013cites this paper
• Glycoconjugate vaccines

  2013cites this paper
• Oral and topical antibiotic prescriptions for children in general practice

  2012cites this paper